Phillips Efficia DFM100 Defibrillator/Monitor

The WA-AED in Perth has been the distributor in Australia of Phillips Efficia DFM100 Defibrillator/Monitor to meet the advanced requirements of hospital code teams, nurses, physicians, and first-responders in the emergency medical service (EMS) environment. The device is easy to use in all modes. It can be used to monitor ECG and optional pulse oximetry (SpO2), non-invasive blood pressure (NBP), and End-tidal Carbon Dioxide (EtCO2).

The Phillips Efficia DFM100 is an affordable solution and can adapt to the changes in the clinical environment. The device possesses the following characteristics.

  • Dependable and easy to use
  • Scalable feature set
  • Enhanced cost of ownership

Device Specifications


  • Rechargeable Lithium-Ion battery
  • C power using a protectively grounded outlet

Approximate Dimensions

  • 23.5 cm (H) x 29 cm (W) x 20.5 cm (D); 9.25 in (H) x 11.4 in (W) x 8 in (D)

Approximate Weight (without battery)

  • 5.66 kg ~ 12.5 lbs

Standard Operator Position

  • Within one meter (3 feet) of the device


  • Rechargeable Lithium-Ion battery & AC power using a protectively grounded outlet



Improving cost-of-ownership

The Efficia DFM100 which is distributed by the WA-AED in Perth helps to deliver care at an affordable price with quality and reliability. This can be proven with more than 1 million Philips defibrillators sold worldwide. Device configurations range from a basic defibrillator to a fully-featured defibrillator/monitor with optional AED mode, pacing, and monitoring parameters. To help minimize the time and cost of staff training, the company has designed the Efficia DFM100 with the same user interface across hospital and EMS versions.

A complete package

To deliver high levels of care, it is important to make quick, informed decisions – at the scene of an emergency and across the entire course of treatment. It is easy to use as you care for a patient. The device monitors the developments in the patient’s condition during transport to the hospital ad up to the level of discharge.

Overview of the device performance

Design of Phillips Efficia DFM100 Defibrillator/Monitor is a lightweight, portable defibrillator/monitor with a large display. It provides four clinical modes of operations namely,

  • Monitor
  • Manual Defibrillation/Synchronized Cardioversion
  • AED
  • Pacing


In Monitor mode, depending on the ECG cable used, 3 different ECG waveforms at one time on the display can be viewed.
Using a 3-lead ECG cable, either Lead I, II or III can be viewed. With a 5-Lead ECG cable, I, II, III, aVR, aVL, aVF or V can be viewed. Optional monitoring of SpO2 (numeric and pleth wave), EtCO2 (numeric and Capnogram), and NBP are available.
Measurements and waves are presented on the display and alarms are available to alert the change in the patient’s condition. It also displays the Vital Signs Trending Report to view all key monitoring parameters and their measurements briefly.

Manual Defibrillation/Synchronized Cardioversion

Manual Defibrillation Mode provides simple 1-2-3 defibrillation. When analyzing the patient’s ECG and, if appropriate set the configuration as follows.

  • Select an energy setting
  • Charge
  • Deliver the shock

Defibrillation is performed using paddles (internal or external) or multifunction electrode pads. Synchronized cardioversion can be performed in Manual Defibrillation Mode.



In the optional AED Mode, the Efficia DFM100 analyzes the patient’s ECG and determines whether a shock is advised. Voice prompts guide through the 2-step defibrillation process, while easy-to-follow instruction and patient information (including Adult and Infant/Child patient categories) appear on the display. Voice prompts are reinforced by messages on the display.


Optional Pacing Mode offers non-invasive transcutaneous pacing therapy. Pace pulses are delivered through multifunction electrode pads in Demand or Fixed modes.

The Phillips Efficia DFM100 Defibrillator/Monitor incorporates Philips’ low energy SMART Biphasic waveform for defibrillation.

The device automatically stores critical event data such as Event Summaries and Vital Signs Trending.

In clinical mode, the Efficia DFM100 continually records data about a patient in an Event Summary record. The recorded data includes vital signs (such as SpO2, and heart rate), ECG wave data, and therapy events (such as shock delivered). The Event Summary can be printed or exported after the patient event is completed. The data can be transported to a USB drive and downloaded to a compatible version of Philips’ data management solution.

The Efficia DFM100 is powered by a rechargeable Lithium-Ion battery. Available battery power is determined by viewing the battery power indicators located on the front of the device, the icon on the display, or by checking the gauge on the battery itself. Additionally, AC Power may be applied as a secondary power source and for continual battery charging.

The Ready For Use (RFU) indicator provides a constant status update, indicating the Efficia DFM100 is ready for use, needs attention, or is unable to deliver therapy. The device performs automated tests on a regular basis and displays results on the RFU indicator.

 In addition, performing specified Operational Checks ensures the Efficia DFM100 is functioning properly. The Efficia DFM100 is highly configurable to better meet the needs of diverse users, including the EMS environment. It is important to familiarize yourself with the device’s configuration before using the Efficia DFM100.



The Efficia DFM100 defibrillator/monitor is designed to meet the demands of patient care in the pre-hospital and hospital environment. With field-proven Philips’s technology, the Efficia DFM100 offers core functionality with a scalable feature set and improved cost of ownership, allowing you to enhance patient care, wherever the patient is located.

ECG Monitoring

The electrocardiogram (ECG) is a recording of the electrical activity of the heart. ECG monitoring allows for the identification and interpretation of cardiac rhythms or dysrhythmias and the calculation of heart rate. ECG on the Efficia DFM100 is obtained by placing electrodes or pads/paddles on the patient and allowing the heart’s electrical activity to be monitored and recorded. The Efficia DFM100 in Monitoring mode requires user interaction to assess the patient’s ECG.

Pulse Oximetry (SpO2) Monitoring

Pulse oximetry is a non-invasive method that checks the saturation of oxygen in the arterial blood. The pulse oximetry functionality in the Efficia DFM100 uses an optical sensor that detects light through the patient’s finger and then measures the received light with a detector. The received light is translated into a saturation percentage and is displayed as a SpO2 reading. The Efficia DFM100 in Monitoring mode requires user interaction to assess the patient’s SpO2.

Non-Invasive Blood Pressure (NBP) Monitoring

The Efficia DFM100 measures the blood pressure of patients by automatically inflating an occluding cuff and using oscillometer measurement techniques to determine systolic, diastolic, mean arterial pressures and pulse. You can manually initiate this measurement, or you can set it to recur at a predetermined interval. The Efficia DFM100 in Monitoring mode requires user interaction to assess the patient’s NBP.

End-Tidal CO2 Monitoring

The EtCO2 functionality in the Efficia DFM100 is a capnometry device that uses non-dispersive infrared spectroscopy to continuously measure the amount of carbon dioxide (CO2) during each breath and report the amount present at the end of exhalation. The sample is obtained by the sidestream method and can be used with intubated and non-intubated patients. Respiration rate is also measured and displayed in breaths per minute. The Efficia DFM100 in Monitoring mode requires user interaction to assess the patient’s EtCO2.


The DFM100 can be used as an Advanced Life Supporter (ALS) in the following use environments,

  • General hospital crash-cart use
  • In the prehospital environment – In a medical emergency through the emergency medical response system

The Efficia DFM100 is intended for use for emergency incidents as follows,

  • In AED mode – Detect a shockable rhythm and deliver a shock
  • In Manual mode – Deliver synchronized and asynchronized defibrillation
  • In Pacing mode – Deliver external cardiac pacing
  • In Monitor mode – Measure heart rate and heart rhythm via ECG, measure blood oxygen saturation via SpO2, measure exhaled CO2 via EtCO2, and measure systolic, diastolic, and mean blood pressure via NBP

The Efficia DFM100 can be used over the following populations as defined by the European Resuscitation Council (ERC).

  • A neonate is a child in the first 28 days of life
  • A newborn is a child just after birth
  • An infant is a child under 1 year
  • A child is between 1 year and puberty
  • From puberty, children are referred to as adolescents, and adult guidelines apply
  • Adult guidelines continue to be applied after adolescence

Safety Considerations

  • The Efficia DFM100 is not intended to be deployed in settings or situations that promote use by untrained personnel. Operation by untrained personnel can result in injury or death.
  • Electric shock hazards exist internally
  • Do not attempt to open the device
  • Refer servicing to qualified personnel
  • Use only supplies and accessories approved for use with your Efficia DFM100
  • Use of non-approved supplies and accessories could affect performance and results
  • Use the Efficia DFM100 on one patient at a time
  • Use single-use supplies and accessories only once

Phillips has designed the Efficia DFM100 with your needs in mind to be reliable, flexible, and affordable. This is what makes the Phillips Efficia DFM100 Defibrillator/Monitor easy to own and easy to use and ultimately that means you can devote your attention to the needs of your patient. The Efficia DFM100 has won the following awards and titles.

  • iF Design Award 2015
  • Singapore Good Design SG Mark winner 2015
  • GIO award 2015
  • Red Dot award 2014
  • Successful Design Award (China) 2014